iShares Biotechnology ETF IBB
Set alert
213.79 USD -3.82 -1.76%
At close · Nov 2
213.60 -0.19 -0.09%
After hours · Nov 2, 5:20 PM ET
213.56 Day range 219.49
154.62 52-week range 222.29
- YTD
- +26.68%
- 1 year
- +34.14%
- Open
- 217.90
- Prev close
- 217.61
- Mkt cap
- 11.50B
- Vol
- 2.05M
- Avg vol
- 1.64M
- EPS
- 8.00
- P/E
- 26.71
- Div yield
- 0.00%
More statistics
- Low
- 213.56
- High
- 219.49
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 208.43
- 200-d avg
- 184.75
- 1y target
- 0.00
1Y chart
Events in this range
- Dec 16, 2025Dividend: 0.1831
- Mar 17, 2026Dividend: 0.12182
- Jun 15, 2026Dividend: 0.023774
- Sep 15, 2026Dividend: 0.011194
Signals (57)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Oct 20, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 20, 2026 | 1 week ago |
| SMA: Bearish | Oct 16, 2026 | 2 weeks ago |
| SMA: Bullish | Oct 15, 2026 | 2 weeks ago |
| SMA: Bearish | Oct 12, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 9, 2026 | 3 weeks ago |
| SMA: Bearish | Oct 6, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 28, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 31, 2026 | 2 months ago |
| RSI: Overbought | Aug 25, 2026 | 2 months ago |
| RSI: Overbought | Aug 21, 2026 | 2 months ago |
| RSI: Overbought | Aug 19, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 14, 2026 | 3 months ago |
| RSI: Overbought | Jun 25, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 11, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 8, 2026 | 4 months ago |
| SMA: Bearish | Jun 5, 2026 | 5 months ago |
| SMA: Bullish | Jun 4, 2026 | 5 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| MACD: Sell Signal | Jun 2, 2026 | 5 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 27, 2026 | 5 months ago |
| SMA: Bullish | May 26, 2026 | 5 months ago |
| SMA: Bearish | May 22, 2026 | 5 months ago |
| SMA: Bullish | May 21, 2026 | 5 months ago |
| SMA: Bearish | May 15, 2026 | 5 months ago |
| MACD: Sell Signal | May 15, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 24, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| SMA: Bullish | Apr 13, 2026 | 6 months ago |
| SMA: Bearish | Apr 10, 2026 | 6 months ago |
| SMA: Bullish | Apr 8, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 31, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bullish | Mar 4, 2026 | 8 months ago |
| SMA: Bearish | Mar 3, 2026 | 8 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 20, 2026 | 8 months ago |
| SMA: Bullish | Feb 13, 2026 | 8 months ago |
| SMA: Bearish | Feb 12, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| SMA: Bearish | Feb 5, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 30, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 22, 2026 | 9 months ago |
| MACD: Sell Signal | Jan 12, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 7, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 5, 2025 | 11 months ago |
| RSI: Overbought | Nov 21, 2025 | 11 months ago |
| RSI: Overbought | Nov 14, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 11, 2025 | 11 months ago |
| RSI: Overbought | Nov 11, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 26.71
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 208.43
- 200-day average
- 184.75
Analyst view
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
News
- Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
- $10,000 in Vanguard's Health Care ETF in 2004 Grew to $93,915, and It Still Charges 0.09%
- Alphabet Posts Worst Week Since 2011, Intel Suffers Record Crash as Warsh Sees 'Cracks': This Week on Wall Street
- Regeneron Surges 13.55%: Here's What It Means for Your Health Care ETFs
- Should You Invest in the iShares Biotechnology ETF (IBB)?
- ETFs That You May Consider Amid a Strengthening Biotech Outlook
- Invesco's RSPH or iShares' IBB: Which Healthcare ETF Is the Better Long-Term Buy?
- Biotech stocks are surging. How investors can play the new drug innovation boom
- Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
- iShares Biotechnology ETF $IBB Shares Sold by Fairvoy Private Wealth LLC
Your note
Sign in to keep a note on IBB — it syncs with the Stock Master app.